346 related articles for article (PubMed ID: 16391261)
1. The effects of quantitative gait assessment and botulinum toxin a on musculoskeletal surgery in children with cerebral palsy.
Molenaers G; Desloovere K; Fabry G; De Cock P
J Bone Joint Surg Am; 2006 Jan; 88(1):161-70. PubMed ID: 16391261
[TBL] [Abstract][Full Text] [Related]
2. Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences.
Molenaers G; Desloovere K; De Cat J; Jonkers I; De Borre L; Pauwels P; Nijs J; Fabry G; De Cock P
Eur J Neurol; 2001 Nov; 8 Suppl 5():88-97. PubMed ID: 11851737
[TBL] [Abstract][Full Text] [Related]
3. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures.
Desloovere K; Molenaers G; Jonkers I; De Cat J; De Borre L; Nijs J; Eyssen M; Pauwels P; De Cock P
Eur J Neurol; 2001 Nov; 8 Suppl 5():75-87. PubMed ID: 11851736
[TBL] [Abstract][Full Text] [Related]
4. Tendon transfer surgery in upper-extremity cerebral palsy is more effective than botulinum toxin injections or regular, ongoing therapy.
Van Heest AE; Bagley A; Molitor F; James MA
J Bone Joint Surg Am; 2015 Apr; 97(7):529-36. PubMed ID: 25834076
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
Dohin B; Garin C; Vanhems P; Kohler R
Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
[TBL] [Abstract][Full Text] [Related]
9. Effect of physiotherapeutic intervention on the gait after the application of botulinum toxin in children with cerebral palsy: systematic review.
Fonseca PR; Calhes Franco de Moura R; Galli M; Santos Oliveira C
Eur J Phys Rehabil Med; 2018 Oct; 54(5):757-765. PubMed ID: 29185676
[TBL] [Abstract][Full Text] [Related]
10. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
Balbaloglu O; Basaran A; Ayoglu H
J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
[TBL] [Abstract][Full Text] [Related]
11. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
[TBL] [Abstract][Full Text] [Related]
12. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
13. The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy.
Hayek S; Gershon A; Wientroub S; Yizhar Z
J Bone Joint Surg Br; 2010 Aug; 92(8):1152-9. PubMed ID: 20675764
[TBL] [Abstract][Full Text] [Related]
14. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
Ubhi T; Bhakta BB; Ives HL; Allgar V; Roussounis SH
Arch Dis Child; 2000 Dec; 83(6):481-7. PubMed ID: 11087280
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
Schasfoort F; Pangalila R; Sneekes EM; Catsman C; Becher J; Horemans H; Stam HJ; Dallmeijer AJ; Bussmann JBJ
J Rehabil Med; 2018 Aug; 50(8):732-742. PubMed ID: 30080235
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin A and physical therapy in gait in cerebral palsy].
García-Sánchez SF; Gómez-Galindo MT; Guzmán-Pantoja JE
Rev Med Inst Mex Seguro Soc; 2017; 55(1):18-24. PubMed ID: 28092243
[TBL] [Abstract][Full Text] [Related]
17. Single-event multilevel surgery, but not botulinum toxin injections normalize joint loading in cerebral palsy patients.
Van Rossom S; Kainz H; Wesseling M; Papageorgiou E; De Groote F; Van Campenhout A; Molenaers G; Desloovere K; Jonkers I
Clin Biomech (Bristol, Avon); 2020 Jun; 76():105025. PubMed ID: 32402900
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy.
Manganotti P; Zaina F; Falso M; Milanese F; Fiaschi A
J Rehabil Med; 2007 Mar; 39(2):115-20. PubMed ID: 17351692
[TBL] [Abstract][Full Text] [Related]
19. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
Preston N; Clarke M; Bhakta B
J Rehabil Med; 2011 Nov; 43(11):1010-5. PubMed ID: 22031347
[TBL] [Abstract][Full Text] [Related]
20. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
